We are live on !
Find out more
US Bancorp Portfolio holdings
AUM
$91.6B
Turnover
10.68%
1-Year Est. Return
29.2%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+29.2%
3 Year Est. Return
+76.81%
5 Year Est. Return
+86.62%
10 Year Est. Return
+295.59%
AUM
$30B
AUM Growth
+$778M
(+2.7%)
Cap. Flow
+$100M
Cap. Flow % of AUM
Cap. Flow %
0.33%
Top 10 Holdings %
Top 10 Hldgs %
23.18%
Holding
3,750
New
145
Increased
1,199
Reduced
1,328
Closed
155
Avg Time Held
3
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$33.8M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$22.9M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$22.4M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$20.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$30.2M |
| 2 |
Valspar
VAL
|
+$28.1M |
| 3 |
Mobileye N.V.
MBLY
|
+$26.8M |
| 4 |
3M
MMM
|
+$17.9M |
| 5 |
Procter & Gamble
PG
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.33% |
| 2 | Industrials | 12.32% |
| 3 | Financials | 11.41% |
| 4 | Healthcare | 10.84% |
| 5 | Technology | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $1.37B | 4.57% |
5,665,578
+104,377
| +2% | +$25M |
2013 Q2
16 quarters
|
|
|
2
3M
MMM
$89.5B
| $1.08B | 3.61% |
6,208,412
-106,836
| -2% | -$17.9M |
2013 Q2
16 quarters
|
|
3
US Bancorp
USB
$92.8B
| $735M | 2.45% |
14,157,826
+259,093
| +2% | +$13.3M |
2013 Q2
16 quarters
|
|
|
4
iShares MSCI EAFE ETF
EFA
$76.2B
| $648M | 2.16% |
9,945,293
+314,445
| +3% | +$20.3M |
2013 Q2
16 quarters
|
|
5
ExxonMobil
XOM
$753B
| $561M | 1.87% |
6,950,542
-147,564
| -2% | -$12.1M |
2013 Q2
16 quarters
|
|
6
Apple
AAPL
$5.07T
| $546M | 1.82% |
15,158,416
-303,280
| -2% | -$11.2M |
2013 Q2
16 quarters
|
|
|
7
Procter & Gamble
PG
$374B
| $525M | 1.75% |
6,023,058
-182,407
| -3% | -$16.1M |
2013 Q2
16 quarters
|
|
8
Johnson & Johnson
JNJ
$635B
| $514M | 1.71% |
3,883,013
-57,237
| -1% | -$7.3M |
2013 Q2
16 quarters
|
|
|
9
iShares Core US Aggregate Bond ETF
AGG
$139B
| $497M | 1.66% |
4,533,861
+205,288
| +5% | +$22.4M |
2013 Q2
16 quarters
|
|
10
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.5B
| $472M | 1.57% |
1,484,570
+56,060
| +4% | +$17.6M |
2013 Q2
16 quarters
|
|
11
Microsoft
MSFT
$3.89T
| $421M | 1.4% |
6,106,148
-27,474
| -0.4% | -$1.89M |
2013 Q2
16 quarters
|
|
|
12
iShares Core MSCI EAFE ETF
IEFA
$188B
| $377M | 1.26% |
6,198,291
+560,434
| +10% | +$33.8M |
2014 Q2
12 quarters
|
|
13
JPMorgan Chase
JPM
$881B
| $329M | 1.1% |
3,597,825
+49,650
| +1% | +$4.28M |
2013 Q2
16 quarters
|
|
14
GE Aerospace
GE
$296B
| $310M | 1.03% |
2,394,829
+50,712
| +2% | +$6.95M |
2013 Q2
16 quarters
|
|
15
iShares Core S&P Small-Cap ETF
IJR
$104B
| $306M | 1.02% |
4,368,132
+94,212
| +2% | +$6.52M |
2013 Q2
16 quarters
|
|
16
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
| $298M | 1% |
2,397,649
+143,447
| +6% | +$17.7M |
2013 Q2
16 quarters
|
|
17
PepsiCo
PEP
$185B
| $297M | 0.99% |
2,569,072
-21,427
| -0.8% | -$2.46M |
2013 Q2
16 quarters
|
|
18
Pfizer
PFE
$171B
| $295M | 0.98% |
9,246,626
-111,251
| -1% | -$3.51M |
2013 Q2
16 quarters
|
|
19
Wells Fargo
WFC
$247B
| $283M | 0.94% |
5,101,195
-114,070
| -2% | -$6.11M |
2013 Q2
16 quarters
|
|
|
20
Vanguard Real Estate ETF
VNQ
$37.2B
| $269M | 0.9% |
3,232,910
+274,391
| +9% | +$22.9M |
2013 Q2
16 quarters
|
|
21
Chevron
CVX
$457B
| $258M | 0.86% |
2,477,656
-28,998
| -1% | -$3.07M |
2013 Q2
16 quarters
|
|
22
iShares MSCI Emerging Markets ETF
EEM
$28.7B
| $231M | 0.77% |
5,571,992
+39,824
| +0.7% | +$1.62M |
2013 Q2
16 quarters
|
|
23
Alphabet (Google) Class A
GOOGL
$3.92T
| $214M | 0.72% |
4,611,580
+72,060
| +2% | +$3.37M |
2015 Q4
6 quarters
|
|
24
AbbVie
ABBV
$505B
| $213M | 0.71% |
2,938,686
-8,875
| -0.3% | -$597K |
2013 Q2
16 quarters
|
|
25
Berkshire Hathaway Class A
BRK.A
$1.16T
| $211M | 0.7% |
828
+20
| +2% | +$4.99M |
2013 Q2
16 quarters
|
|
Similar funds
US Bancorp's Q2 2017 Portfolio in Review
As of Q2 2017, US Bancorp held 3,750 positions worth $30B, up 2.7% from $29.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q2 2017 filing shows 145 new, 1,199 increased, 1,328 reduced and 155 closed positions. Its largest new stake was DXC Technology: 95,517 shares worth $6.34M. The largest sale was Cardinal Health, an estimated $30.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- US Bancorp's largest Q2 2017 buy was DXC Technology: 95,517 shares worth $6.34M.
- US Bancorp added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $33.8M increase.
- US Bancorp's biggest Q2 2017 reduction was Cardinal Health, cutting an estimated $30.2M.
- US Bancorp fully exited Valspar in Q2 2017, selling an estimated $28.1M.
- US Bancorp's ten largest holdings make up 23% of its $30B portfolio in Q2 2017.
- US Bancorp opened 145 new positions and closed 155 in Q2 2017.
- US Bancorp's portfolio value rose 2.7% quarter-over-quarter to $30B.
Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.